MUSK and myasthenia gravis: Especially the high portion of thymus hyperplasia in our cohort might argue for low-affinity antibodies since thymic pathologies in MG are known to produce AChR-antibodies [12], but 75% of double negative patients (AChR and MuSK) showed lymph node-type infiltrates in thymus similar to AChR-MG [13].